Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer

Clinical trial NCT01573468 · UNKNOWN

Trial details

NCT number: NCT01573468
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Carcinoma

Start date: 2012-04-01
Primary completion: 2014-07-01
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.